ArticleAnnals of the rheumatic diseases1999
Does social disadvantage contribute to the excess mortality in rheumatoid arthritis patients?
Article in Annals of the rheumatic diseases, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Comparative study of intramuscular gold and methotrexate in a rheumatoid arthritis population from a socially deprived area.Annals of the rheumatic diseases · 2001Trial
- Burden of Emergency Department Visits and Their Outcomes Among Patients With Rheumatoid Arthritis: Insights From the Nationwide Emergency Department Sample.ACR open rheumatology · 2025Article
- The association between social determinants of health and all-cause, cardiovascular mortality in US rheumatoid arthritis: a cohort study of NHANES.BMC public health · 2025Article
- Socioeconomic Status and Medication Use in Rheumatoid Arthritis: A Scoping Review.Arthritis care & research · 2023Article
- Educational inequalities in mortality associated with rheumatoid arthritis and other musculoskeletal disorders in Sweden.BMC musculoskeletal disorders · 2019Article
- Article
- Impact of managed care health insurance system for indigent patients with rheumatoid arthritis in Puerto Rico.Clinical rheumatology · 2013Article
- Association between socioeconomic status, learned helplessness, and disease outcome in patients with inflammatory polyarthritis.Arthritis care & research · 2012Article
- Arthritis, occupational class, and the aging US workforce.American journal of public health · 2011Article
- Socioeconomic determinants of disability and depression in patients with rheumatoid arthritis.Arthritis care & research · 2011Article
- Socioeconomic disparities in pain: the role of economic hardship and daily financial worry.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2011Article
- Association of functional outcome with both personal- and area-level socioeconomic inequalities in patients with inflammatory polyarthritis.Arthritis and rheumatism · 2009Article
- Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study.Annals of the rheumatic diseases · 2005Article
- Disease activity and health status in rheumatoid arthritis: a case-control comparison between Norway and Lithuania.Annals of the rheumatic diseases · 2003Article
- Socioeconomic deprivation and rheumatoid disease: what lessons for the health service? ERAS Study Group. Early Rheumatoid Arthritis Study.Annals of the rheumatic diseases · 2000Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSocioeconomic deprivation is associated with increased mortality from cardiovascular causes and malignancy. The influence of disadvantage in patients with rheumatoid arthritis (RA), who are known to have premature mortality, has not been ascertained.
aimTo assess the relation between the level of patient deprivation and mortality in RA patients.
methods200 RA patients, enrolled in a study comparing sulfasalazine and penicillamine in 1984-85, have been followed up prospectively for 12 years. Subjects were categorised into Carstairs groups with deprivation scores ranging from 1 (most affluent) to 7 (most deprived). Information about deaths was obtained from the Registrar General in Scotland, death certificates and GP/hospital records.
resultsThere were more RA patients in the deprived areas then expected compared with the West of Scotland and England and Wales. Some 47.5% of the RA patients had died by 12 years-the majority of cardiorespiratory causes or malignancy. There were no differences in the median age or disease duration in the various Carstairs groups at study entry, but the percentage of deaths was higher in the more deprived groups after 12 years (36% dead in most affluent area compared with 61% in the most deprived, that is, in groups 6 and 7).
conclusionIn patients with RA increasing deprivation was associated with premature mortality. If confirmed elsewhere these findings have implications for rheumatological management strategies, for researchers involved in collaborative studies of patients from different socioeconomic backgrounds and for resource allocation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.